Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Blood|July 29, 2018
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphomaTammy Linlin Song, Maarja-Liisa Nairismägi, Yurike Laurensia, et al.
Blood Cancer Journal|January 29, 2020
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphomaSanjay de Mel, Masturah B M Rashid, Xi Yun Zhang, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2022
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical PracticeCatalina Amador, Alyssa Bouska, George Wright, et al.
Blood|March 18, 2014
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaJaveed Iqbal, George Wright, Chao Wang, et al.
Blood|March 17, 2021
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphomaXiao-Peng Tian, Shu-Yun Ma, Ken H Young, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in AsiaSang Eun Yoon, Yuqin Song, Seok Jin Kim, et al.
Haematologica|January 13, 2022
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOSCho Mar Myint Wai, Shangying Chen, The Phyu, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Blood|July 29, 2018
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphomaTammy Linlin Song, Maarja-Liisa Nairismägi, Yurike Laurensia, et al.
Blood Cancer Journal|January 29, 2020
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphomaSanjay de Mel, Masturah B M Rashid, Xi Yun Zhang, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Clinical Epigenetics|February 5, 2023
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamideJinghong Chen, Zhixiang Zuo, Yan Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2022
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical PracticeCatalina Amador, Alyssa Bouska, George Wright, et al.
Blood|March 18, 2014
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaJaveed Iqbal, George Wright, Chao Wang, et al.
Blood|March 17, 2021
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphomaXiao-Peng Tian, Shu-Yun Ma, Ken H Young, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in AsiaSang Eun Yoon, Yuqin Song, Seok Jin Kim, et al.
Haematologica|January 13, 2022
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOSCho Mar Myint Wai, Shangying Chen, The Phyu, et al.
Pageof 19